- Investing Ideas
- Global Pharmaceuticals & Biotech High Risk Large Caps
Global Pharmaceuticals & Biotech High Risk Large Caps
Results
6
Are you holding one of these? A list of some of the most volatile large-cap stocks over the past five years.
6 companies
Natera
Market Cap: US$28.7b
A diagnostics company, engages in the development and commercialization of molecular testing services worldwide.
NTRA
US$195.28
7D
4.0%
1Y
29.2%
BioNTech
Market Cap: US$21.4b
Engages in the development and commercialization of immunotherapies in Germany.
BNTX
US$89.27
7D
-2.1%
1Y
-6.4%
Illumina
Market Cap: US$19.4b
Provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa.
ILMN
US$124.33
7D
4.5%
1Y
41.8%
Sam Chun Dang Pharm
Market Cap: ₩21.1t
Engages in the manufacturing and sale of pharmaceutical products in South Korea.
A000250
₩907,000.00
7D
17.5%
1Y
380.4%
Regencell Bioscience Holdings
Market Cap: US$13.5b
Operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong.
RGC
US$27.37
7D
17.8%
1Y
1,673.9%
Elanco Animal Health
Market Cap: US$12.5b
An animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide.
ELAN
US$23.98
7D
4.5%
1Y
127.7%